Taufiq Rahman

Dr. Taufiq Rahman

Department of Pharmacology, University of Cambridge
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2010 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
EBEugen Brailoiu
Eugen Brailoiu
Taufiq RahmanTaufiq Rahman
Taufiq Rahman
DCDev Churamani
Dev Churamani
DPDavid L. Prole
David L. Prole
GBG. Cristina Brailoiu
G. Cristina Brailoiu
SPSandip Patel
Sandip Patel
Nicotinic acid adenine dinucleotide phosphate (NAADP) is a ubiquitous messenger proposed to stimulate Ca2+ release from acidic organelles via two-pore channels (TPCs). It has been difficult to resolve this trigger event from its amplification via endoplasmic reticulum Ca2+ stores, fuelling speculation that archetypal intracellular Ca2+ channels are the primary targets of NAADP. Here, we redirect TPC2 from lysosomes to the plasma membrane and show that NAADP evokes Ca2+ influx independent of ryanodine receptors and that it activates a Ca2+-permeable channel whose conductance is reduced by mutation of a residue within a putative pore. We therefore uncouple TPC2 from amplification pathways and prove that it is a pore-forming subunit of an NAADP-gated Ca2+ channel.

16 September 2014 in Microbiologyopen
Verified
Journal Article
Open access
PDF file
TOThelma Ohene‐Agyei
Thelma Ohene‐Agyei
RMRumana Mowla
Rumana Mowla
Taufiq RahmanTaufiq Rahman
Taufiq Rahman
Henrietta VenterHenrietta Venter
Henrietta Venter
Drug efflux pumps confer resistance upon bacteria to a wide range of antibiotics from various classes. The expression of efflux pumps are also implicated in virulence and biofilm formation. Moreover, organisms can only acquire resistance in the presence of active drug efflux pumps. Therefore, efflux pump inhibitors (EPIs) are attractive compounds to reverse multidrug resistance and to prevent the development of resistance in clinically relevant bacterial pathogens. We investigated the potential of pure compounds isolated from plants to act as EPIs. In silico screening was used to predict the bioactivity of plant compounds and to compare that with the known EPI, phe-arg-β-naphthylamide (PAβN). Subsequently, promising products have been tested for their ability to inhibit efflux. Plumbagin nordihydroguaretic acid (NDGA) and to a lesser degree shikonin, acted as sensitizers of drug-resistant bacteria to currently used antibiotics and were able to inhibit the efflux pump-mediated removal of substrate from cells. We demonstrated the feasibility of in silico screening to identify compounds that potentiate the action of antibiotics against drug-resistant strains and which might be potentially useful lead compounds for an EPI discovery program.

18 November 2014 in Science Signaling
Verified
Journal Article
Closed access
PDF file
Taufiq RahmanTaufiq Rahman
Taufiq Rahman
Xinjiang CaiXinjiang Cai
Xinjiang Cai
GBG. Cristina Brailoiu
G. Cristina Brailoiu
MAMary Abood
Mary Abood
EBEugen Brailoiu
Eugen Brailoiu
SPSandip Patel
Sandip Patel
Four-domain voltage-gated Ca2+ and Na+ channels (CaV, NaV) underpin nervous system function and likely emerged upon intragenic duplication of a primordial two-domain precursor. To investigate if two-pore channels (TPCs) may represent an intermediate in this evolutionary transition, we performed molecular docking simulations with a homology model of TPC1, which suggested that the pore region could bind antagonists of CaV or NaV. CaV or NaV antagonists blocked NAADP (nicotinic acid adenine dinucleotide phosphate)–evoked Ca2+ signals in sea urchin egg preparations and in intact cells that overexpressed TPC1. By sequence analysis and inspection of the model, we predicted a noncanonical selectivity filter in animal TPCs in which the carbonyl groups of conserved asparagine residues are positioned to coordinate cations. In contrast, a distinct clade of TPCs [TPCR (for TPC-related)] in several unicellular species had ion selectivity filters with acidic residues more akin to CaV. TPCRs were predicted to interact strongly with CaV antagonists. Our data suggest that acquisition of a “blueprint” pharmacological profile and changes in ion selectivity within four-domain voltage-gated ion channels may have predated intragenic duplication of an ancient two-domain ancestor.

1 July 2019 in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Verified
Journal Article
Closed access
CPChristopher J. Penny
Christopher J. Penny
KVKristin Vassileva
Kristin Vassileva
AJArchana Jha
Archana Jha
YYYu Yuan
Yu Yuan
XCXavier Chee
Xavier Chee
SPSandip Patel
Sandip Patel

9 August 2009 in Nature Chemical Biology
Verified
Journal Article
Open access
PDF file
ARAna M Rossi
Ana M Rossi
ARAndrew M Riley
Andrew M Riley
STStephen C Tovey
Stephen C Tovey
Taufiq RahmanTaufiq Rahman
Taufiq Rahman
ODOlivier DELLIS
Olivier DELLIS
CTColin W Taylor
Colin W Taylor
Inositol 1,4,5-trisphosphate receptors (IP3Rs) are ubiquitous intracellular Ca2+ channels. IP3 binding to the IP3-binding core (IBC) near the N terminus initiates conformational changes that lead to opening of a pore. The mechanisms underlying this process are unresolved. We synthesized 2-O–modified IP3 analogs that are partial agonists of IP3R. These are similar to IP3 in their interactions with the IBC, but they are less effective than IP3 in rearranging the relationship between the IBC and the N-terminal suppressor domain (SD), and they open the channel at slower rates. IP3R with a mutation in the SD occupying a position similar to the 2-O substituent of the partial agonists has a reduced open probability that is similar for full and partial agonists. Bulky or charged substituents from either the ligand or the SD therefore block obligatory coupling of the IBC and the SD. Analysis of ΔG for ligand binding shows that IP3 is recognized by the IBC and conformational changes then propagate entirely via the SD to the pore.

16 October 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SRSaifur Rahman
Saifur Rahman
Taufiq RahmanTaufiq Rahman
Taufiq Rahman
The store-operated calcium entry (SOCE) pathway is an important route for generating cytosolic Ca2+ signals that regulate a diverse array of biological processes. Abnormal SOCE seem to underlie several diseases that notably include allergy, inflammation and cancer. Therefore, any modulator of this pathway is likely to have significant impact in cell biology under both normal and abnormal conditions. In this study, we screened the FDA-approved drug library for agents that share significant similarity in 3D shape and surface electrostatics with few, hitherto best known inhibitors of SOCE. This has led to the identification of five drugs that showed dose-dependent inhibition of SOCE in cell-based assay, probably through interacting with the Orai1 protein which effectively mediates SOCE. Of these drugs, leflunomide and teriflunomide could suppress SOCE significantly at clinically-relevant doses and this provides for an additional mechanism towards the therapeutic utility of these drugs as immunosuppressants. The other three drugs namely lansoprazole, tolvaptan and roflumilast, were less potent in suppressing SOCE but were more selective and thus they may serve as novel scaffolds for future development of new, more efficacious SOCE inhibitors.